Wallaby Medical Launches pRESET Stentriever in Brazil

Date: 2022-08-19    Wallaby Medical

Laguna Hills, Shanghai & Bochum, Aug 22, 2022 - Wallaby Medical ("Wallaby" or the "Company"), a global innovative medical technology company focused on developing and commercializing neurovascular interventional products for treating stroke, recently announced that the pRESET thrombectomy device has been successfully launched in Brazil.  

The pRESET device is a stentriever which is used for mechanical thrombectomy in patients with acute ischemic stroke, due to large vessel occlusion.

Michael Alper, CEO of Wallaby: “We look forward to helping patients in LATAM with our best-in-class pRESET thrombectomy device. Our goal is to provide the best neurovascular solutions to our physician partners while being an easy company to work with so that we can work together to save the most lives affected by stroke. ”

Peter Cooke, President Global Commercial: “As commercial leader, I am delighted to announce the launch of pRESET in Brazil. Saving patient’ s lives is at the absolute core of phenox and the purpose of its employees. The future is bright for phenox and Wallaby Medical.”

©2022 Wallaby Medical. All Rights Reserved     |  Privacy Statement     Official Wechat

©2022 Wallaby Medical. All Rights Reserved
Privacy Statement
Official Wechat